BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cocozzelli AG, White TW. Connexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease. Int J Mol Sci 2019;20:E6186. [PMID: 31817921 DOI: 10.3390/ijms20246186] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 O'Shaughnessy EM, Duffy W, Garcia-Vega L, Hussey K, Burden AD, Zamiri M, Martin PE. Dysregulation of Connexin Expression Plays a Pivotal Role in Psoriasis. Int J Mol Sci 2021;22:6060. [PMID: 34199748 DOI: 10.3390/ijms22116060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Giuliani AL, Sarti AC, Di Virgilio F. Ectonucleotidases in Acute and Chronic Inflammation. Front Pharmacol 2020;11:619458. [PMID: 33613285 DOI: 10.3389/fphar.2020.619458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Orellana VP, Tittarelli A, Retamal MA. Connexins in melanoma: Potential role of Cx46 in its aggressiveness. Pigment Cell Melanoma Res 2021;34:853-68. [PMID: 33140904 DOI: 10.1111/pcmr.12945] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Laird DW, Lampe PD. Cellular mechanisms of connexin-based inherited diseases. Trends Cell Biol 2021:S0962-8924(21)00147-1. [PMID: 34429228 DOI: 10.1016/j.tcb.2021.07.007] [Reference Citation Analysis]
5 Subedi YP, Altenberg GA, Chang CT. Advances in the development of connexin hemichannel inhibitors selective toward Cx43. Future Med Chem 2021;13:379-92. [PMID: 33399487 DOI: 10.4155/fmc-2020-0291] [Reference Citation Analysis]
6 Marsh SR, Williams ZJ, Pridham KJ, Gourdie RG. Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine. J Cardiovasc Dev Dis 2021;8:52. [PMID: 34063001 DOI: 10.3390/jcdd8050052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Au A, Shao Q, White KK, Lucaciu SA, Esseltine JL, Barr K, Laird DW. Comparative Analysis of Cx31 and Cx43 in Differentiation-Competent Rodent Keratinocytes. Biomolecules 2020;10:E1443. [PMID: 33066499 DOI: 10.3390/biom10101443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Garcia-Vega L, O'Shaughnessy EM, Albuloushi A, Martin PE. Connexins and the Epithelial Tissue Barrier: A Focus on Connexin 26. Biology (Basel) 2021;10:59. [PMID: 33466954 DOI: 10.3390/biology10010059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Natha CM, Vemulapalli V, Fiori MC, Chang CT, Altenberg GA. Connexin hemichannel inhibitors with a focus on aminoglycosides. Biochim Biophys Acta Mol Basis Dis 2021;1867:166115. [PMID: 33711451 DOI: 10.1016/j.bbadis.2021.166115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yang TT, Qian F, Liu L, Peng XC, Huang JR, Ren BX, Tang FR. Astroglial connexins in epileptogenesis. Seizure 2021;84:122-8. [PMID: 33348235 DOI: 10.1016/j.seizure.2020.11.022] [Reference Citation Analysis]
11 Yang P, Davidson JO, Fowke TM, Galinsky R, Wassink G, Karunasinghe RN, Prasad JD, Ranasinghe S, Green CR, Bennet L, Gunn AJ, Dean JM. Connexin Hemichannel Mimetic Peptide Attenuates Cortical Interneuron Loss and Perineuronal Net Disruption Following Cerebral Ischemia in Near-Term Fetal Sheep. Int J Mol Sci 2020;21:E6475. [PMID: 32899855 DOI: 10.3390/ijms21186475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bedoukian EC, Rentas S, Skraban C, Shao Q, Treat J, Laird DW, Sullivan KE. Palmoplantar keratoderma with deafness phenotypic variability in a patient with an inherited GJB2 frameshift variant and novel missense variant. Mol Genet Genomic Med 2021;9:e1574. [PMID: 33443819 DOI: 10.1002/mgg3.1574] [Reference Citation Analysis]